insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...

insights from industryDr. Thierry Le BihanPrincipal Scientist Rapid Novor Inc. In this interview, News-Medical spoke to Dr. Thierry Le Bihan, Principal Scientist for the REpAb™ project, about how ...

Blood collected from survivors of COVID-19 has been used to identify antibodies against the disease, which have been turned into experimental drugs to fight it. But it’s not an easy process. So back ...

RANCHO CORDOVA, Calif., April 13, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...

Grifols picked up a 44% stake in GigaGen in 2017 when the duo teamed up to develop polyclonal antibodies under a $50 million pact. Now, the Spanish pharma is dropping $80 million to acquire the ...

Antibodies are a stalwart tool in biomedical research. Most commonly used are animal-derived polyclonal and monoclonal antibodies (mAbs), and nonanimal-derived recombinant mAbs. According to Simon ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Black widow spiders are among the world’s most venomous spiders ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

Scientists create monoclonal antibodies by cloning a single antibody-producing cell line. In contrast to polyclonal antibodies, monoclonals are highly specific to an antigen. By fusing myeloma cells ...